SQUAMOUS CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets gene mutation in hard-to-treat lung cancer
Disease control Recruiting nowThis study tests a drug called ZEN003694 in people with advanced squamous cell lung cancer that has a change in the NSD3 gene. The drug blocks certain proteins that may help the cancer grow. Researchers want to see if it can shrink tumors or slow the disease. About 13 participant…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:55 UTC
-
Engineered immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowThis early-phase study tests a new treatment called C-CAR031 for people with advanced squamous cell lung cancer that has not responded to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target a protein called GPC3 found on cancer cells. …
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated May 26, 2026 06:49 UTC